
Arcutis grants 44,000 restricted stock units to six new hires as inducement under Nasdaq rules.
Arcutis Biotherapeutics awarded 44,000 restricted stock units to six newly hired employees as part of its 2022 Inducement Plan, approved by its board's Compensation Committee. These stock units vest over four years, with 25% vesting annually, conting...


